Browsing Tag
breast cancer diagnostics
2 posts
I-SPY 2 data puts Natera’s Signatera at the center of early breast cancer risk debates
Natera’s I-SPY 2 data suggests ctDNA may finally align early breast cancer risk with treatment intensity. Read why this matters for payers and markets.
Inoviq’s breakthrough breast cancer test neuCA15-3 shows unparalleled accuracy
Inoviq Limited, an emerging leader in biotechnology, has announced a significant advancement in breast cancer detection. The company…